Mycoplasma pneumoniae Antibody, IgM
Also known as: MYCO-M
Use
The Mycoplasma pneumoniae Antibody, IgM test is used to detect the presence of IgM antibodies specific to Mycoplasma pneumoniae. Mycoplasma pneumoniae is a common cause of respiratory infections, including pneumonia. The detection of IgM antibodies indicates a recent or current infection with Mycoplasma pneumoniae. This test aids in the diagnosis of Mycoplasma pneumoniae infections, allowing for appropriate clinical management and treatment.
Special Instructions
Specimens should be marked as 'acute' or 'convalescent' as required. Convalescent specimens must be received within 30 days from the receipt of the acute specimens. Parallel testing is preferred for accuracy.
Limitations
This test detects IgM antibodies which may occasionally persist for more than 12 months post-infection. Low levels of IgM antibodies may not indicate an acute infection. Follow-up testing is recommended to confirm reactivity in cases of low positive results.
FDA ApprovedNew York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 5256-3
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.1 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate serum from cells as soon as possible or within 2 hours of collection. Transfer to a transport tube.
Storage Instructions
Refrigerated storage is preferred. Avoid repeated freeze/thaw cycles.
Causes for Rejection
Bacterially contaminated, heat-inactivated, hemolyzed, icteric, lipemic, or turbid specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |